By Ana Mano SAO PAULO (Reuters) - Brazilian meatpacker JBS SA defended the structure of a proposed dual listing that will go to shareholders for approval this month, saying on Wednesday that the plan is an attractive value proposition to investors in the long term. If approved by minority shareholders on May 23, the plan - originally announced in 2023 - would see the world's biggest meat company primarily listed in New York with Brazilian depositary receipts traded in Sao Paulo. The Institutional Shareholder Services (ISS), an advisory firm for matters of corporate governance, has argued the proposal could potentially weaken minority shareholders' rights. In a call with analysts to discuss first-quarter results on Wednesday, JBS' Chief Financial Officer Guilherme Cavalcanti said the proposed structure ensures the company will retain a strong controlling shareholder that fully understands the sector. "In our industry, it is very important that you have defined control," he said. "And control defined by people who understand the business, who have a track record ... This is the best format." JBS' current controlling shareholder is the Batista family's J&F investment group. In a letter sent to shareholders obtained by Reuters, JBS criticized ISS's position. "ISS clearly fails to recognize the long-term commitment and strategic importance of the controlling shareholder's role and contribution in achieving JBS' leadership in the global food industry," it wrote. JBS NV, the Dutch company created for the dual listing, will issue Class A and Class B shares. Under the proposed structure, the Class B shares will have 10 times the voting power of Class A shares, and only Class A shares will be publicly traded. In one potential scenario, JBS' controlling shareholders could end up with 85% of voting power. All shareholders will be able to convert Class A into Class B shares, Cavalcanti told the analysts. In private talks with investors, he said JBS managers have been urging all the company's shareholders to back the dual listing, but he added that he could not predict the vote's outcome. JBS recently received a green-light from the U.S. Securities and Exchange Commission to go ahead with the plan, meaning its shares could start trading in New York next month. Should the plan be rejected by the minority shareholders, however, it would need to file for a new SEC approval, a process that would take three to six months to complete, Cavalcanti said. (Reporting by Ana Mano, Editing by Louise Heavens and Joe Bavier) View Comments
Brazil's JBS defends dual listing proposal following criticism
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...